Glycomic analysis of ovarian cancer: Past, present, and future

Cancer Biomarkers

Volumn 8, Issue 4-5, 2010, Pages 273-280

  Abbott, Karen L ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN; CELL SURFACE RECEPTOR; COMPLEMENTARY DNA; FUCOSE; GALACTOSE; GALECTIN; GLYCAN; GLYCOPROTEIN; GLYCOSYLTRANSFERASE; LECTIN; N ACETYLGLUCOSAMINE; OLIGOSACCHARIDE; PEANUT AGGLUTININ; SIALIC ACID; TRANSCRIPTOME; TUMOR MARKER; WHEAT GERM AGGLUTININ;

ARTICLE; CANCER DIAGNOSIS; EARLY DIAGNOSIS; EPITHELIUM CELL; FEMALE; FUCOSYLATION; GLYCOBIOLOGY; GLYCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID ANALYSIS; LOTUS; MALIGNANT TRANSFORMATION; MASS SPECTROMETRY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; RICINUS COMMUNIS; TUMOR CELL; TUMOR GROWTH; WESTERN BLOTTING;

FEMALE; GLYCOMICS; HUMANS; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 81155132135     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2011-0218     Document Type: Article

References (46)

1. D. Sasaroli, G. Coukos and N. Scholler, Beyond CA125: the coming of age of ovarian cancer biomarkers, Arewe there yet? Biomark Med 3 (2009), 275-288.
2. T.I. Williams, K.L. Toups, D.A. Saggese, K.R. Kalli, W.A. Cliby and D.C. Muddiman, Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers, J Proteome Res 6 (2007), 2936-2962. (Pubitemid 47310180)
3. J.C. Aub, B.H. Sanford and L.H. Wang, Reactions of normal and leukemic cell surfaces to a wheat germ agglutinin, Proc Natl Acad Sci U S A 54 (1965), 400-402.
4. S. Hakomori, Glycosylation defining cancer malignancy: new wine in an old bottle, Proc Natl Acad Sci U S A 99 (2002), 10231-10233.
5. M.J. Pierce, Cancer Glycomics, in: Handbook of Glycomics, R.D. Cummings and M.J. Pierce, eds, Elsevier, San Diego, 2009.
6. R. Garcia-Bunuel and B. Monis, Histochemical Observations on Mucins in Human Ovarian Neoplasms, Cancer 17 (1964), 1108-1118.
7. C.W. Gehrke, T.P.Waalkes, E. Borek, W.F. Swartz, T.F. Cole, K.C. Kuo, M. Abeloff, D.S. Ettinger, N. Rosenshein and R.C. Young, Quantitative gas-liquid chromatography of neutral sugars in human serum glycoproteins. Fucose, mannose, and galactose as predictors in ovarian and small cell lung carcinoma, J Chromatogr 162 (1979), 507-528. (Pubitemid 9147050)
8. S.K. Chatterjee, M. Bhattacharya and J.J. Barlow, Glycosyltransferase and glycosidase activities in ovarian cancer patients, Cancer Res 39 (1979), 1943-1951. (Pubitemid 9184982)
9. K.O. Soderstrom, Lectin binding to serous ovarian tumours, J Clin Pathol 41 (1988), 308-313. (Pubitemid 18091050)
10. M.T. Goodarzi and G.A. Turner, Decreased branching, increased fucosylation and changed sialylation of alpha-1- proteinase inhibitor in breast and ovarian cancer, Clin Chim Acta 236 (1995), 161-171.
11. A.V. Nairn, W.S. York, K. Harris, E.M. Hall, J.M. Pierce and K.W. Moremen, Regulation of glycan structures in animal tissues: transcript profiling of glycan-related genes, J Biol Chem 283 (2008), 17298-17313.
12. S.R. Kronewitter, M.L. de Leoz, K.S. Peacock, K.R.McBride, H.J.An, S.Miyamoto, G.S. Leiserowitz andC.B. Lebrilla, Human serum processing and analysis methods for rapid and reproducible N-glycan mass profiling, J Proteome Res 9 (2010), 4952-4959.
13. K.T. Pilobello, L.Krishnamoorthy, D. Slawek and L.K.Mahal, Development of a lectin microarray for the rapid analysis of protein glycopatterns, Chembiochem 6 (2005), 985-989. (Pubitemid 40825336)
14. K.L. Abbott, J.M. Lim, L. Wells, B.B. Benigno, J.F. McDonald and M. Pierce, Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis, Proteomics 10 (2010), 470-481.
15. H.J. An, S. Miyamoto, K.S. Lancaster, C. Kirmiz, B. Li, K.S. Lam, G.S. Leiserowitz and C.B. Lebrilla, Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer, J Proteome Res 5 (2006), 1626-1635. (Pubitemid 44043097)
16. Y.H. Ahn, Y.S. Kim, E.S. Ji, J.Y. Lee, J.A. Jung, J.H. Ko and J.S. Yoo, Comparative quantitation of aberrant glycoforms by lectin-based glycoprotein enrichment coupled with multiplereaction monitoring mass spectrometry, Anal Chem 82 (2010), 4441-4447.
17. S.Yanagidani, N.Uozumi, Y. Ihara, E. Miyoshi, N.Yamaguchi and N. Taniguchi, Purification and cDNA cloning of GDPL- Fuc:N-acetyl-beta-D- glucosaminide:alpha1-6 fucosyltransferase (alpha1-6 FucT) from human gastric cancer MKN45 cells, J Biochem 121 (1997), 626-632. (Pubitemid 27145920)
18. Y. Yamaguchi, Y. Ikeda, T. Takahashi, H. Ihara, T. Tanaka, C. Sasho, N. Uozumi, S. Yanagidani, S. Inoue, J. Fujii and N. Taniguchi, Genomic structure and promoter analysis of the human alpha1, 6-fucosyltransferase gene (FUT8), Glycobiology 10 (2000), 637-643. (Pubitemid 30398419)
19. T. Takahashi, Y. Ikeda, E. Miyoshi, Y. Yaginuma, M. Ishikawa and N. Taniguchi, alpha1,6fucosyltransferase is highly and specifically expressed in human ovarian serous adenocarcinomas, Int J Cancer 88 (2000), 914-919.
20. B.W. Yin, A. Dnistrian and K.O. Lloyd, Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene, Int J Cancer 98 (2002), 737-740. (Pubitemid 34225625)
21. A. Nagata, N. Hirota, T. Sakai, M. Fujimoto and T. Komoda, Molecular nature and possible presence of a membranous glycan-phosphatidylinositol anchor of CA125 antigen, Tumour Biol 12 (1991), 279-286.
22. N. Kui Wong, R.L. Easton, M. Panico, M. Sutton-Smith, J.C. Morrison, F.A. Lattanzio, H.R. Morris, G.F. Clark, A. Dell and M.S. Patankar, Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125, J Biol Chem 278 (2003), 28619-28634. (Pubitemid 36935768)
23. P.H.Wang, W.L. Lee, C.M. Juang, Y.H. Yang, W.H. Lo, C.R. Lai, S.L. Hsieh and C.C. Yuan, Altered mRNA expressions of sialyltransferases in ovarian cancers, Gynecol Oncol 99 (2005), 631-639.
24. G.S. Leiserowitz, C. Lebrilla, S. Miyamoto, H.J. An, H. Duong, C. Kirmiz, B. Li, H. Liu and K.S. Lam, Glycomics analysis of serum: a potential new biomarker for ovarian cancer? Int J Gynecol Cancer 18 (2008), 470-475. (Pubitemid 351668296)
25. D.A. Barkauskas, H.J. An, S.R. Kronewitter, M.L. de Leoz, H.K. Chew, R.W. de Vere White, G.S. Leiserowitz, S. Miyamoto, C.B. Lebrilla and D.M. Rocke, Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data, Bioinformatics 25 (2009), 251-257.
26. H.J. An and C.B. Lebrilla, A glycomics approach to the discovery of potential cancer biomarkers, Methods Mol Biol 600 (2010), 199-213.
27. R. Saldova, L. Royle, C.M. Radcliffe, U.M. Abd Hamid, R. Evans, J.N. Arnold, R.E. Banks, R. Hutson, D.J. Harvey, R. Antrobus, S.M. Petrescu, R.A. Dwek and P.M. Rudd, Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG, Glycobiology 17 (2007), 1344-1356. (Pubitemid 350131311)
28. K.L. Abbott, A.V. Nairn, E.M. Hall, M.B. Horton, J.F. Mc- Donald, K.W. Moremen, D.M. Dinulescu and M. Pierce, Focused glycomic analysis of the N-linked glycan biosynthetic pathway in ovarian cancer, Proteomics 8 (2008), 3210-3220.
29. H.H. Wandall, O. Blixt, M.A. Tarp, J.W. Pedersen, E.P. Bennett, U. Mandel, G. Ragupathi, P.O. Livingston, M.A. Hollingsworth, J. Taylor-Papadimitriou, J. Burchell and H. Clausen, Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes, Cancer Res 70 (2010), 1306-1313.
30. H. Clausen and E.P. Bennett, A family of UDP-GalNAc: polypeptide N-acetylgalactosaminyl-transferases control the initiation of mucin-type O-linked glycosylation, Glycobiology 6 (1996), 635-646. (Pubitemid 26386377)
31. T. Ju, K. Brewer, A. D'Souza, R.D. Cummings and W.M. Canfield, Cloning and expression of human core 1 beta1,3- galactosyltransferase, J Biol Chem 277 (2002), 178-186. (Pubitemid 34952043)
32. T. Ju and R.D. Cummings, Protein glycosylation: chaperone mutation in Tn syndrome, Nature 437 (2005), 1252. (Pubitemid 41568663)
33. K.L. Abbott and J.M. Pierce, Lectin-based glycoproteomic techniques for the enrichment and identification of potential biomarkers, Methods Enzymol 480 (2010), 461-476.
34. C.C. Wang, J.C. Lee, S.Y. Luo, S.S. Kulkarni, Y.W. Huang, C.C. Lee, K.L. Chang and S.C. Hung, Regioselective one-pot protection of carbohydrates, Nature 446 (2007), 896-899. (Pubitemid 46646620)
35. A. Francais, D. Urban and J.M. Beau, Tandem catalysis for a one-pot regioselective protection of carbohydrates: the example of glucose, Angew Chem Int Ed Engl 46 (2007), 8662-8665. (Pubitemid 350189088)
36. J.D. Codee, L.J. van den Bos, R.E. Litjens, H.S. Overkleeft, J.H. van Boom and G.A. van der Marel, Sequential one-pot glycosylations using 1-hydroxyl and 1-thiodonors, Org Lett 5 (2003), 1947-1950. (Pubitemid 37161965)
37. D.P. Galonic and D.Y. Gin, Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines, Nature 446 (2007), 1000-1007. (Pubitemid 46691044)
38. G.D. MacLean, M.A. Reddish, R.R. Koganty and B.M. Longenecker, Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine, J Immunother Emphasis Tumor Immunol 19 (1996), 59-68. (Pubitemid 26127867)
39. S.F. Slovin, G. Ragupathi, S. Adluri, G. Ungers, K. Terry, S. Kim,M. Spassova,W.G. Bornmann, M. Fazzari, L. Dantis, K. Olkiewicz, K.O. Lloyd, P.O. Livingston, S.J. Danishefsky and H.I. Scher, Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man, Proc Natl Acad Sci U S A 96 (1999), 5710-5715. (Pubitemid 29234683)
40. S.F. Slovin, G. Ragupathi, C. Musselli, K. Olkiewicz, D. Verbel, S.D. Kuduk, J.B. Schwarz, D. Sames, S. Danishefsky, P.O. Livingston and H.I. Scher, Fully synthetic carbohydratebased vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-Oserine/ threonine conjugate vaccine, J Clin Oncol 21 (2003), 4292-4298. (Pubitemid 46621804)
41. T. Buskas, P. Thompson and G.J. Boons, Immunotherapy for cancer: synthetic carbohydrate-based vaccines, Chem Commun (Camb) 36 (2009), 5335-5349.
42. C.F. Teo, S. Ingale, M.A. Wolfert, G.A. Elsayed, L.G. Not, J.C. Chatham, L.Wells and G.J. Boons, Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc, Nat Chem Biol 6 (2010), 338-343.
43. K.E. Scarberry, E.B. Dickerson, Z.J. Zhang, B.B. Benigno and J.F. McDonald, Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles, Nanomedicine 6 (2010), 399-408.
44. E.De Clercq, Antiviral agents active against influenza A viruses, Nat Rev Drug Discov 5 (2006), 1015-1025. (Pubitemid 44835128)
45. I. Capila and R.J. Linhardt, Heparin-protein interactions, Angew Chem Int Ed Engl 41 (2002), 391-412.
46. A. Banzato, S. Bobisse, M. Rondina, D. Renier, F. Bettella, G. Esposito, L. Quintieri, L. Melendez-Alafort, U. Mazzi, P. Zanovello and A. Rosato, A paclitaxel-hyaluronan bioconjugate targeting ovarian cancer affords a potent in vivo therapeutic activity, Clin Cancer Res 14 (2008), 3598-3606.